speb/financial-data huggingface dataset:
MYSZ balance_sheet (quarterly, 2024-12-31) — Current Provisions: 164000.00
MYSZ cash_flow (annual, 2024-12-31) — Deferred Income Tax: 0.00
MYSZ cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 0.00
MYSZ cash_flow (annual, 2024-12-31) — Deferred Tax: 0.00
MYSZ cash_flow (quarterly, 2024-12-31) — Deferred Tax: 0.00
MYSZ cash_flow (annual, 2024-12-31) — Depreciation: 20000.00
MYSZ cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 314000.00
MYSZ cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 314000.00
MYSZ income_statement (annual, 2024-12-31) — Diluted Average Shares: 910758.00
MYSZ income_statement (annual, 2024-12-31) — Diluted EPS: -4.39
MYSZ income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -3995000.00
MYSZ balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 151000.00
MYSZ income_statement (annual, 2024-12-31) — EBIT: -3588000.00
MYSZ income_statement (annual, 2024-12-31) — EBITDA: -3274000.00
MYSZ income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 0.00
MYSZ income_statement (quarterly, 2024-12-31) — Earnings From Equity Interest: 0.00
MYSZ cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 61000.00
MYSZ cash_flow (annual, 2024-12-31) — End Cash Position: 4880000.00
MYSZ cash_flow (annual, 2024-12-31) — Financing Cash Flow: 5594000.00
MYSZ cash_flow (annual, 2024-12-31) — Free Cash Flow: -3099000.00
MYSZ cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 29000.00
MYSZ cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 1000.00
MYSZ income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -87000.00
MYSZ balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -825000.00
MYSZ income_statement (annual, 2024-12-31) — General And Administrative Expense: 3368000.00
MYSZ balance_sheet (annual, 2024-12-31) — Goodwill: 133000.00
MYSZ balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 883000.00
MYSZ balance_sheet (annual, 2024-12-31) — Gross PPE: 139000.00
MYSZ income_statement (annual, 2024-12-31) — Gross Profit: 3323000.00
MYSZ income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 631000.00
MYSZ income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 0.00
MYSZ income_statement (annual, 2024-12-31) — Insurance And Claims: 359000.00
MYSZ income_statement (annual, 2024-12-31) — Interest Expense: 78000.00
MYSZ income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 78000.00
MYSZ income_statement (annual, 2024-12-31) — Interest Income: 114000.00
MYSZ income_statement (annual, 2024-12-31) — Interest Income Non Operating: 114000.00
MYSZ cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -41000.00
MYSZ balance_sheet (annual, 2024-12-31) — Inventory: 2796000.00
MYSZ balance_sheet (annual, 2024-12-31) — Invested Capital: 7162000.00
MYSZ cash_flow (annual, 2024-12-31) — Investing Cash Flow: 53000.00
MYSZ balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 7000.00
MYSZ balance_sheet (annual, 2024-12-31) — Investments And Advances: 7000.00
MYSZ balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 0.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Investmentsin Joint Venturesat Cost: 0.00
MYSZ cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 5829000.00
MYSZ cash_flow (annual, 2024-12-31) — Issuance Of Debt: 500000.00
MYSZ balance_sheet (annual, 2024-12-31) — Leases: 2000.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Leases: 2000.00
MYSZ balance_sheet (annual, 2024-12-31) — Loans Receivable: 0.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Loans Receivable: 0.00
MYSZ balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 8000.00
MYSZ balance_sheet (annual, 2024-12-31) — Long Term Debt: 146000.00
MYSZ balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 154000.00
MYSZ cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 500000.00
MYSZ cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -735000.00
MYSZ balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 0.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 0.00
MYSZ balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 114000.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 114000.00
MYSZ cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 38000.00
MYSZ cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
MYSZ cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 5829000.00
MYSZ cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
MYSZ income_statement (annual, 2024-12-31) — Net Income: -3995000.00
MYSZ income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -3995000.00
MYSZ income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -3995000.00
MYSZ income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3995000.00
MYSZ income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3995000.00
MYSZ cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -3995000.00
MYSZ income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -3995000.00
MYSZ income_statement (annual, 2024-12-31) — Net Interest Income: -51000.00
MYSZ cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 22000.00
MYSZ cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
MYSZ cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -235000.00
MYSZ cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -235000.00
MYSZ income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -51000.00
MYSZ balance_sheet (annual, 2024-12-31) — Net PPE: 90000.00
MYSZ cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -7000.00
MYSZ balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 6026000.00
MYSZ balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 7000.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 7000.00
MYSZ income_statement (annual, 2024-12-31) — Normalized EBITDA: -2918000.00
MYSZ income_statement (annual, 2024-12-31) — Normalized Income: -3639000.00
MYSZ cash_flow (annual, 2024-12-31) — Operating Cash Flow: -3092000.00
MYSZ cash_flow (annual, 2024-12-31) — Operating Gains Losses: 29000.00
MYSZ cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 1000.00
MYSZ income_statement (annual, 2024-12-31) — Operating Income: -3588000.00
MYSZ income_statement (annual, 2024-12-31) — Operating Revenue: 8257000.00
MYSZ balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 2040159.00
MYSZ balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 107000.00
MYSZ balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 121000.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 121000.00
MYSZ balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -825000.00
MYSZ income_statement (annual, 2024-12-31) — Other Gand A: 3368000.00
MYSZ income_statement (annual, 2024-12-31) — Other Income Expense: -356000.00
MYSZ income_statement (quarterly, 2024-12-31) — Other Income Expense: 181000.00
MYSZ balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 750000.00
MYSZ cash_flow (annual, 2024-12-31) — Other Non Cash Items: 47000.00
MYSZ cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -138000.00
MYSZ balance_sheet (annual, 2024-12-31) — Other Payable: 639000.00
MYSZ balance_sheet (annual, 2024-12-31) — Other Properties: 23000.00
MYSZ balance_sheet (annual, 2024-12-31) — Other Receivables: 786000.00
MYSZ balance_sheet (annual, 2024-12-31) — Payables: 2235000.00
MYSZ balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2503000.00
MYSZ balance_sheet (annual, 2024-12-31) — Prepaid Assets: 332000.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 332000.00
MYSZ income_statement (annual, 2024-12-31) — Pretax Income: -3995000.00
MYSZ balance_sheet (annual, 2024-12-31) — Properties: 0.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
MYSZ cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
MYSZ cash_flow (annual, 2024-12-31) — Purchase Of PPE: -7000.00
MYSZ balance_sheet (annual, 2024-12-31) — Receivables: 1064000.00
MYSZ income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 4934000.00
MYSZ income_statement (annual, 2024-12-31) — Reconciled Depreciation: 314000.00
MYSZ income_statement (annual, 2024-12-31) — Rent And Landing Fees: 296000.00
MYSZ income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 296000.00
MYSZ cash_flow (annual, 2024-12-31) — Repayment Of Debt: -735000.00
MYSZ income_statement (annual, 2024-12-31) — Research And Development: 429000.00
MYSZ balance_sheet (annual, 2024-12-31) — Restricted Cash: 0.00
MYSZ balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 0.00
MYSZ income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: -275000.00
MYSZ balance_sheet (annual, 2024-12-31) — Retained Earnings: -63876000.00
MYSZ income_statement (annual, 2024-12-31) — Salaries And Wages: 1876000.00
MYSZ cash_flow (annual, 2024-12-31) — Sale Of Business: 38000.00
MYSZ cash_flow (quarterly, 2024-12-31) — Sale Of Business: 0.00
MYSZ cash_flow (annual, 2024-12-31) — Sale Of Investment: 22000.00
MYSZ cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
MYSZ income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 3114000.00
MYSZ income_statement (annual, 2024-12-31) — Selling General And Administration: 6482000.00
MYSZ balance_sheet (annual, 2024-12-31) — Share Issued: 2040159.00
MYSZ income_statement (annual, 2024-12-31) — Special Income Charges: -356000.00
MYSZ income_statement (quarterly, 2024-12-31) — Special Income Charges: 268000.00
MYSZ cash_flow (annual, 2024-12-31) — Stock Based Compensation: 390000.00
MYSZ balance_sheet (annual, 2024-12-31) — Stockholders Equity: 6909000.00
MYSZ balance_sheet (annual, 2024-12-31) — Tangible Book Value: 6026000.00
MYSZ income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
MYSZ income_statement (annual, 2024-12-31) — Tax Provision: 0.00
MYSZ income_statement (quarterly, 2024-12-31) — Tax Provision: 0.00
MYSZ income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
MYSZ balance_sheet (annual, 2024-12-31) — Total Assets: 10059000.00
MYSZ balance_sheet (annual, 2024-12-31) — Total Capitalization: 7055000.00
MYSZ balance_sheet (annual, 2024-12-31) — Total Debt: 276000.00
MYSZ balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 6909000.00
MYSZ income_statement (annual, 2024-12-31) — Total Expenses: 11845000.00
MYSZ balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3150000.00
MYSZ balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 987000.00
MYSZ balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 154000.00
MYSZ income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -3944000.00
MYSZ income_statement (annual, 2024-12-31) — Total Other Finance Cost: 51000.00
MYSZ income_statement (annual, 2024-12-31) — Total Unusual Items: -356000.00
MYSZ income_statement (quarterly, 2024-12-31) — Total Unusual Items: 181000.00
MYSZ income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -356000.00
MYSZ income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 181000.00
MYSZ cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -1000.00
MYSZ balance_sheet (annual, 2024-12-31) — Working Capital: 6076000.00
MYSZ income_statement (quarterly, 2025-03-31) — +Operating Expense: 1480000.00
MYSZ income_statement (quarterly, 2025-03-31) — +Total Revenue: 1479000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1588000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 534000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 71767000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 38000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 38000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 14000.00
MYSZ income_statement (quarterly, 2025-03-31) — Basic Average Shares: 2093949.00
MYSZ income_statement (quarterly, 2025-03-31) — Basic EPS: -0.51
MYSZ cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 4880000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 19000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 3695000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 3695000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 95000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 0.00
MYSZ cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -1268000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -497000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Change In Inventory: 331000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 4000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -80000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Change In Payable: -311000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -311000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Change In Receivables: -209000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -265000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -256000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1173000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 6029000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 137000.00
MYSZ income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1059000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Current Assets: 7804000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 17000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Current Debt: 77000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 94000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2587000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Depreciation: 4000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 42000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 42000.00
MYSZ income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 2093949.00
MYSZ income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.51
MYSZ income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1060000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 72000.00
MYSZ income_statement (quarterly, 2025-03-31) — EBIT: -1060000.00
MYSZ income_statement (quarterly, 2025-03-31) — EBITDA: -1018000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -12000.00
MYSZ cash_flow (quarterly, 2025-03-31) — End Cash Position: 3695000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 95000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1268000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -804000.00
MYSZ income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 831000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Goodwill: 133000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 845000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Gross PPE: 81000.00
MYSZ income_statement (quarterly, 2025-03-31) — Gross Profit: 420000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -2000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Inventory: 2504000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Invested Capital: 6239000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 0.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 14000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 14000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 137000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 2000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 133000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 135000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
MYSZ cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -42000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
MYSZ cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 137000.00
MYSZ income_statement (quarterly, 2025-03-31) — Net Income: -1060000.00
MYSZ income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1060000.00
MYSZ income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1060000.00
MYSZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1060000.00
MYSZ income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1060000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1060000.00
MYSZ income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1060000.00
MYSZ income_statement (quarterly, 2025-03-31) — Net Interest Income: 0.00
MYSZ cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
MYSZ cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -42000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -42000.00
MYSZ income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 0.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Net PPE: 81000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5184000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 7000.00
MYSZ income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1018000.00
MYSZ income_statement (quarterly, 2025-03-31) — Normalized Income: -1060000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -1268000.00
MYSZ income_statement (quarterly, 2025-03-31) — Operating Income: -1060000.00
MYSZ income_statement (quarterly, 2025-03-31) — Operating Revenue: 1479000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 2110748.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 77000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -804000.00
MYSZ income_statement (quarterly, 2025-03-31) — Other Gand A: 831000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 712000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Other Payable: 833000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Other Properties: 81000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1071000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Payables: 2493000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 2493000.00
MYSZ income_statement (quarterly, 2025-03-31) — Pretax Income: -1060000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Receivables: 1605000.00
MYSZ income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1059000.00
MYSZ income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 42000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -42000.00
MYSZ income_statement (quarterly, 2025-03-31) — Research And Development: 82000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -64936000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Sale Of Business: 0.00
MYSZ cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
MYSZ income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 567000.00
MYSZ income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1398000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Share Issued: 2110748.00
MYSZ cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 22000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6029000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5184000.00
MYSZ income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MYSZ income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Total Assets: 8751000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6162000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Total Debt: 229000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6029000.00
MYSZ income_statement (quarterly, 2025-03-31) — Total Expenses: 2539000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2722000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 947000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 135000.00
MYSZ income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1060000.00
MYSZ cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -7000.00
MYSZ balance_sheet (quarterly, 2025-03-31) — Working Capital: 5217000.00
MYSZ income_statement (quarterly, 2025-06-30) — +Operating Expense: 1566000.00
MYSZ income_statement (quarterly, 2025-06-30) — +Total Revenue: 2006000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 914000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 398000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 73662000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 51000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 51000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 14000.00
MYSZ income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3091735.00
MYSZ income_statement (quarterly, 2025-06-30) — Basic EPS: -0.15
MYSZ cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 3695000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 17000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 4282000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 4282000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 1795000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -54000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1038000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -673000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Change In Inventory: -340000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 1000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 291000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Change In Payable: -1164000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -1164000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Change In Receivables: 377000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -835000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 138000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Changes In Cash: 703000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Common Stock: 3000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 7414000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 1850000.00
MYSZ income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 882000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Current Assets: 8413000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 15000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Current Debt: 80000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 95000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2161000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Depreciation: 11000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 62000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 62000.00
MYSZ income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3091735.00
MYSZ income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.15
MYSZ income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -450000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 54000.00
MYSZ income_statement (quarterly, 2025-06-30) — EBIT: -442000.00
MYSZ income_statement (quarterly, 2025-06-30) — EBITDA: -380000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -116000.00
MYSZ cash_flow (quarterly, 2025-06-30) — End Cash Position: 4282000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 1795000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1054000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -865000.00
MYSZ income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 904000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Goodwill: 142000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1337000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Gross PPE: 98000.00
MYSZ income_statement (quarterly, 2025-06-30) — Gross Profit: 1124000.00
MYSZ income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 144000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Interest Paid Cfo: -3000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Inventory: 2901000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Invested Capital: 7586000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -54000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 14000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 14000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 1850000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 2000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 92000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 94000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
MYSZ cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -55000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: -45000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 1850000.00
MYSZ income_statement (quarterly, 2025-06-30) — Net Income: -450000.00
MYSZ income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -450000.00
MYSZ income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -450000.00
MYSZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -450000.00
MYSZ income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -450000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -450000.00
MYSZ income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -450000.00
MYSZ income_statement (quarterly, 2025-06-30) — Net Interest Income: 136000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 7000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -55000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -55000.00
MYSZ income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 136000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Net PPE: 98000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -16000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 6077000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 0.00
MYSZ income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -236000.00
MYSZ income_statement (quarterly, 2025-06-30) — Normalized Income: -306000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1038000.00
MYSZ income_statement (quarterly, 2025-06-30) — Operating Income: -442000.00
MYSZ income_statement (quarterly, 2025-06-30) — Operating Revenue: 2006000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 3103076.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 80000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -865000.00
MYSZ income_statement (quarterly, 2025-06-30) — Other Gand A: 904000.00
MYSZ income_statement (quarterly, 2025-06-30) — Other Income Expense: -144000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 1195000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 193000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Other Payable: 1098000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Other Properties: 98000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Other Receivables: 832000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Payables: 2066000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 2066000.00
MYSZ income_statement (quarterly, 2025-06-30) — Pretax Income: -450000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -16000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Receivables: 1230000.00
MYSZ income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 882000.00
MYSZ income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 62000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -55000.00
MYSZ income_statement (quarterly, 2025-06-30) — Research And Development: 142000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -65386000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Sale Of Business: 0.00
MYSZ cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 7000.00
MYSZ income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 520000.00
MYSZ income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1424000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Share Issued: 3103076.00
MYSZ income_statement (quarterly, 2025-06-30) — Special Income Charges: -144000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 46000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 7414000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 6077000.00
MYSZ income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
MYSZ income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
MYSZ income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Total Assets: 9862000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 7506000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Total Debt: 189000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 7414000.00
MYSZ income_statement (quarterly, 2025-06-30) — Total Expenses: 2448000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2448000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1449000.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 287000.00
MYSZ income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -586000.00
MYSZ income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -136000.00
MYSZ income_statement (quarterly, 2025-06-30) — Total Unusual Items: -144000.00
MYSZ income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -144000.00
MYSZ cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 0.00
MYSZ balance_sheet (quarterly, 2025-06-30) — Working Capital: 6252000.00
MYSZ income_statement (quarterly, 2025-09-30) — +Operating Expense: 2365000.00
MYSZ income_statement (quarterly, 2025-09-30) — +Total Revenue: 2572000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1273000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 506000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 74874000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 137000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 137000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 14000.00
MYSZ income_statement (quarterly, 2025-09-30) — Basic Average Shares: 3313569.00
MYSZ income_statement (quarterly, 2025-09-30) — Basic EPS: -0.40
MYSZ cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 4282000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 13000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Capital Stock: 4000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 4493000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 4493000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 820000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -142000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -500000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1150000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Change In Inventory: -444000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -15000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -303000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Change In Payable: 1336000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1336000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Change In Receivables: 91000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 665000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -2000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Changes In Cash: 178000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Common Stock: 4000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 7296000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 859000.00
MYSZ income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1563000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Current Assets: 9087000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 13000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Current Debt: 101000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 114000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3333000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Depreciation: 9000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 146000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 146000.00
MYSZ income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 3313569.00
MYSZ income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.40
MYSZ income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1335000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 69000.00
MYSZ income_statement (quarterly, 2025-09-30) — EBIT: -1356000.00
MYSZ income_statement (quarterly, 2025-09-30) — EBITDA: -1210000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 33000.00
MYSZ cash_flow (quarterly, 2025-09-30) — End Cash Position: 4493000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 820000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -500000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -861000.00
MYSZ income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1000000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Goodwill: 686000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2458000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Gross PPE: 85000.00
MYSZ income_statement (quarterly, 2025-09-30) — Gross Profit: 1009000.00
MYSZ income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
MYSZ cash_flow (quarterly, 2025-09-30) — Interest Paid Cfo: -1000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Inventory: 3345000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8229000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -142000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 14000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 24000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Investmentsin Joint Venturesat Cost: 10000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 859000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 0.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 832000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 832000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
MYSZ cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -39000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 10000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: -142000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 859000.00
MYSZ income_statement (quarterly, 2025-09-30) — Net Income: -1335000.00
MYSZ income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1335000.00
MYSZ income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -1335000.00
MYSZ income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -1335000.00
MYSZ income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -1335000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -1335000.00
MYSZ income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -1335000.00
MYSZ income_statement (quarterly, 2025-09-30) — Net Interest Income: 21000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
MYSZ cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -39000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -39000.00
MYSZ income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 21000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Net PPE: 85000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4838000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 0.00
MYSZ income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -1210000.00
MYSZ income_statement (quarterly, 2025-09-30) — Normalized Income: -1335000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -500000.00
MYSZ income_statement (quarterly, 2025-09-30) — Operating Income: -1356000.00
MYSZ income_statement (quarterly, 2025-09-30) — Operating Revenue: 2572000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 3848979.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 101000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -861000.00
MYSZ income_statement (quarterly, 2025-09-30) — Other Gand A: 1000000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1772000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 193000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Other Payable: 1877000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Other Properties: 85000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Other Receivables: 743000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Payables: 3219000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3219000.00
MYSZ income_statement (quarterly, 2025-09-30) — Pretax Income: -1335000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -142000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Receivables: 1249000.00
MYSZ income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1563000.00
MYSZ income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 146000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -39000.00
MYSZ income_statement (quarterly, 2025-09-30) — Research And Development: 131000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -66721000.00
MYSZ cash_flow (quarterly, 2025-09-30) — Sale Of Business: 0.00
MYSZ cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
MYSZ income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1234000.00
MYSZ income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2234000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Share Issued: 3848979.00
MYSZ income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
MYSZ cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 16000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 7296000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4838000.00
MYSZ income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
MYSZ income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
MYSZ income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Total Assets: 11654000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 8128000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Total Debt: 946000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 7296000.00
MYSZ income_statement (quarterly, 2025-09-30) — Total Expenses: 3928000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4358000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2567000.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1025000.00
MYSZ income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -1356000.00
MYSZ income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -21000.00
MYSZ income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
MYSZ income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
MYSZ cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
MYSZ balance_sheet (quarterly, 2025-09-30) — Working Capital: 5754000.00
MYSZ income_statement (annual, 2025-12-31) — +Operating Expense: 8596000.00
MYSZ income_statement (quarterly, 2025-12-31) — +Operating Expense: 3185000.00
MYSZ income_statement (annual, 2025-12-31) — +Total Revenue: 9362000.00
MYSZ income_statement (quarterly, 2025-12-31) — +Total Revenue: 3305000.00
MYSZ balance_sheet (annual, 2025-12-31) — Accounts Payable: 2221000.00
MYSZ balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2221000.00
MYSZ balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1214000.00
MYSZ balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1214000.00
MYSZ balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -63000.00
MYSZ balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -63000.00
MYSZ balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 75590000.00
MYSZ balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 75590000.00
MYSZ cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 324000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 98000.00
MYSZ cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 324000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 98000.00
MYSZ cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 144000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
MYSZ balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 2000.00
MYSZ balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 2000.00
MYSZ income_statement (annual, 2025-12-31) — Basic Average Shares: 3136976.00
MYSZ income_statement (annual, 2025-12-31) — Basic EPS: -1.87
MYSZ cash_flow (annual, 2025-12-31) — Beginning Cash Position: 4880000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 4493000.00
MYSZ cash_flow (annual, 2025-12-31) — Capital Expenditure: -16000.00
MYSZ balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 111000.00
MYSZ balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 111000.00
MYSZ balance_sheet (annual, 2025-12-31) — Capital Stock: 5000.00
MYSZ balance_sheet (quarterly, 2025-12-31) — Capital Stock: 5000.00
MYSZ balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 2303000.00
MYSZ balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 2303000.00
MYSZ balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2303000.00
MYSZ balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 2303000.00
MYSZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2995000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 285000.00
MYSZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -196000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 0.00
MYSZ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -5142000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2336000.00
MYSZ cash_flow (annual, 2025-12-31) — Change In Account Payable: 82000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 102000.00
MYSZ cash_flow (annual, 2025-12-31) — Change In Inventory: -142000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Change In Inventory: 311000.00
MYSZ cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 7000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 17000.00
MYSZ cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -70000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 22000.00
MYSZ cash_flow (annual, 2025-12-31) — Change In Payable: 555000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Change In Payable: 694000.00
MYSZ cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 555000.00
MYSZ cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 694000.00